Patients with obesity-related heart failure who took semaglutide 2.4 mg weekly lost substantial weight and reported fewer ...

Right ventricular dysfunction (RVD) is prevalent in 41.7 percent of patients with heart failure with preserved ejection fraction (HFpEF).

A new robotic heart can recreate different stages of heart failure, potentially giving researchers a new way to test ...

Starting a statin may improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF) who are initially free from atherosclerotic cardiovascular disease (ASCVD), according to ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jennifer E. Ho, MD ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Patients with heart failure with preserved ejection fraction (HFpEF) represent approximately 50% of all HF cases. Whereas several proven medical therapies are available for HF with reduced ejection ...

BOSTON, MA—Tirzepatide improves outcomes in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, no matter how much excess body weight they have, according to an analysis ...

Diastolic dysfunction with ventricular stiffening and diffuse fibrosis underpins HFpEF, with hypertension, T2D, AF, CKD, CAD, and adiposity acting as key mechanistic and management modifiers.

Right ventricular dysfunction (RVD) is prevalent in 41.7 percent of patients with heart failure with preserved ejection ...